Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports
Go Back
View Our Subscription Options

Search

Descriptive Alt Text

Filters

Showing results 1,793–1,800 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Genmab A/S Tisotumab vedotin - (innovaTV 207) Squamous cell carcinoma of the head and neck (SCCHN) Phase 2 Data Released Intravenous Oncology
Genocea Biosciences Inc Ordinary Shares GEN-004 Universal vaccine candidate against pneumococcus Phase 2 Intramuscular Immunology
Genprex Inc. Oncoprex With Tarceva Non-small cell lung cancer (NSCLC) Phase 2 Intravenous with oral Oncology
GeoVax Labs Inc. GEO-CM04S1- (COH04S1) COVID-19 in immunocompromised patients Phase 2 Ongoing Intramuscular COVID-19
GeoVax Labs Inc. COVID-19 booster with GEO-CM04S1 or Pfizer-BioNTech Bivalent vaccine COVID-19 Infection, Chronic Lymphocytic Leukemia Phase 2 Data Released Intramuscular Oncology
Geron Corporation Imetelstat - (IMpactMF) Myelofibrosis (MF) Phase 3 Enrollment Initiation Intravenous Hematology
Geron Corporation Imetelstat - (IMpress) Myelodysplastic Syndromes Phase 2 Data Released Intravenous Hematology
GH Research PLC GH1001 (GH001-BD-202) Bipolar II Disorder Phase 2a Ongoing Intranasal Psychiatric
1…223224225226227…553
Your trusted source for drug reimbursement data and buy-and-bill insights.
Platform
Resources
Tools
Search Drugs
Newsletter
Reimbursement updates, drug pricing news.
© 2026 BuyandBill.com, All Rights Reserved.
HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, America's Health Insurance Plans, and Blue Cross and Blue Shield Association). CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.